by RJ Shara | Oct 24, 2020 | Fundings and Exit, Startups
Welcome back to The TechCrunch Exchange. Information reveals that India’s venture capital scene has actually grown dramatically in recent years. Let’s dig in. , TechCrunch noted a number of start-ups from India that stood out from the batch. After a somewhat average start to the year, Indian start-ups saw their venture capital financial investment fall to just $1.5 billion in Q2, the most affordable quarterly tally given that 2016. That figure was not a historic record, mind; the Q3 total looks to be just the fourth-biggest VC quarter in India’s start-up history given that at least 2013 and, possibly, ever. All informed, 2019 was a substantial year for the Indian startup market in endeavor capital terms, and 2020’s recovery is underway. Startups focused on health-related matters (telemedicine, psychological health, AI, etc.) just had a record quarter….
by RJ Shara | Oct 20, 2020 | Fundings and Exit, Startups
This morning Root Insurance, a neo-insurance supplier that has actually drawn in sufficient personal capital for its auto-insurance organization, is targeting an appraisal of as much as $6.34 billion in its pending IPO. The former start-up follows insurtech leader Lemonade to the public markets during a year in which IPOs have been well-received by financiers focused more […] The start-up will raise over $500 million from the shares it is offering in its regular offering. Will we see Root enhance its target? And what does Root’s IPO cost range mean for insurtech startups? Will we see Root’s IPO cost increase?…
by RJ Shara | Sep 24, 2020 | Fundings and Exit, Startups
Throughout the week’s news cycle one particular little bit of reporting slipped under our radar: Root Insurance is tipped by Reuters to be prepping an IPO that could value the neo-insurance provider at around $6 billion. Coming after 2 2020 insurtech IPOs, Root’s actions towards the general public markets are not surprising. They are excellent news [ …]
As tech stocks dip, is insurtech startup Root targeting an IPO? Coming after 2 2020 insurtech IPOs, Root’s actions towards the public markets are not unexpected. First, does Root make sense at a$6 billion assessment? That said, we can still get somewhere about what Root might be worth. As previously when we discovered that Hippo’s private evaluation looked light compared to Lemonade’s public appraisal when we contrasted their valuation/gross written premium numerous, we discovered that MetroMile and Root likewise looked cheap….
Recent Comments